Literature DB >> 1438641

Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia.

R W Dittmann1, M E Kappes, M H Kappes.   

Abstract

As part of a comprehensive interview study, 34 female patients with congenital adrenal hyperplasia (CAH) plus 14 control sisters (ages 11-41 yr.) reported on their psychosexual development and sexual orientation (90 items). Fewer patients than sisters had ever experienced love relationships and sexual activities with male partners (p < 0.05 to 0.001). Twenty percent of the patients and none of the sisters wished for and/or had had homosexual relationships; in the patients > 21 yr 44% expressed this interest (p < 0.07). For most items, patients with the salt-wasting variant of CAH (SW) differed more clearly from the sisters than the simple-virilizing patients (SV). For two scales "indicating" homosexual (HOM) and heterosexual orientation (HET) and for two indices of HOM/HET differences), the patients also revealed relatively stronger homosexual and/or weaker heterosexual interests than the sisters (p < 0.05 to 0.001). Here, too, the SW/sister differences were more clear-cut. These results corroborate earlier reports on both delays in reaching psychosexual milestones and increased rates of bisexual/homosexual fantasies and experiences in CAH women.

Entities:  

Mesh:

Year:  1992        PMID: 1438641     DOI: 10.1016/0306-4530(92)90054-b

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  24 in total

1.  Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects.

Authors:  D K Gupta; Sharma Shilpa; A C Amini; M Gupta; Gautam Aggarwal; Gupta Deepika; Khatri Kamlesh
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

2.  Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH).

Authors:  Vickie Pasterski; Peter Hindmarsh; Mitchell Geffner; Charles Brook; Caroline Brain; Melissa Hines
Journal:  Horm Behav       Date:  2007-06-06       Impact factor: 3.587

3.  The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life.

Authors:  H J van der Kamp; F M Slijper
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

4.  Cognitive functioning in female patients with 21-hydroxylase deficiency.

Authors:  R W Dittmann; M H Kappes; M E Kappes
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-01       Impact factor: 4.785

Review 5.  Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma.

Authors:  A D Fisher; J Ristori; E Fanni; G Castellini; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-06-10       Impact factor: 4.256

6.  Development and familiality of sexual orientation in females.

Authors:  A M Pattatucci; D H Hamer
Journal:  Behav Genet       Date:  1995-09       Impact factor: 2.805

7.  Homosexuality, type 1: an Xq28 phenomenon.

Authors:  W J Turner
Journal:  Arch Sex Behav       Date:  1995-04

8.  An Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  Traci L Schaeffer; Jeanie B Tryggestad; Ashwini Mallappa; Adam E Hanna; Sowmya Krishnan; Steven D Chernausek; Laura J Chalmers; William G Reiner; Brad P Kropp; Amy B Wisniewski
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-18

9.  Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  T H Johannsen; C P L Ripa; E Carlsen; J Starup; O H Nielsen; M Schwartz; K T Drzewiecki; E L Mortensen; K M Main
Journal:  Int J Pediatr Endocrinol       Date:  2010-10-20

Review 10.  Intersex(es) and informed consent: how physicians' rhetoric constrains choice.

Authors:  J David Hester
Journal:  Theor Med Bioeth       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.